Esperion Therapeutics
ESPR
#6822
Rank
โ‚ฌ0.41 B
Marketcap
2,13ย โ‚ฌ
Share price
8.06%
Change (1 day)
150.31%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -โ‚ฌ37.63 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚ฌ0.27 Billion. In 2023 the company made an earning of -โ‚ฌ0.15 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ37.63 Million-73.15%
2023 -โ‚ฌ0.15 Billion-15.03%
2022 -โ‚ฌ0.17 Billion-20.61%
2021 -โ‚ฌ0.21 Billion84.28%
2020 -โ‚ฌ0.12 Billion35.75%
2019 -โ‚ฌ83.03 Million-55.71%
2018 -โ‚ฌ0.19 Billion19.57%
2017 -โ‚ฌ0.16 Billion125.39%
2016 -โ‚ฌ69.56 Million51.43%
2015 -โ‚ฌ45.94 Million36.45%
2014 -โ‚ฌ33.67 Million43.55%
2013 -โ‚ฌ23.46 Million145.26%
2012 -โ‚ฌ9.57 Million
2002 -โ‚ฌ27.27 Million-7.81%
2001 -โ‚ฌ29.57 Million15.03%
2000 -โ‚ฌ25.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.49 Billion 1,177.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.36 B-1,061.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ1.14 Billion 2,878.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.63 B-12,310.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ93.1 Million 145.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.19 Billion 396.60%๐Ÿ‡บ๐Ÿ‡ธ USA